Avanos Medical Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Avanos Medical's estimated annual revenue is currently $736.2M per year.(i)
  • Avanos Medical's estimated revenue per employee is $416,638
  • Avanos Medical's current valuation is $1.6B. (January 2022)

Employee Data

  • Avanos Medical has 1767 Employees.(i)
  • Avanos Medical grew their employee count by 9% last year.

Avanos Medical's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
Head MarketingReveal Email/Phone
4
VP, Global Human ResourcesReveal Email/Phone
5
VP & General Manager Europe, RIT & LATAMReveal Email/Phone
6
VP Global Strategy and MarketingReveal Email/Phone
7
VP Sales, PainReveal Email/Phone
8
VP, Commercial OperationsReveal Email/Phone
9
SVP QualityReveal Email/Phone
10
Head Open InnovationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.3M29N/AN/AN/A
#2
$104.7M4173%N/AN/A
#3
$6M24-23%N/AN/A
#4
$5M400%$16MN/A
#5
$6M24-23%N/AN/A
#6
$10.8M435%N/AN/A
#7
$3M240%$50MN/A
#8
$10M40-13%N/AN/A
#9
$5M2011%N/AN/A
#10
$17.6M703%N/AN/A
Add Company

What Is Avanos Medical?

Avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries.

keywords:N/A

N/A

Total Funding

1767

Number of Employees

$736.2M

Revenue (est)

9%

Employee Growth %

$1.6B

Valuation

N/A

Accelerator

Avanos Medical News

2022-04-13 - Avanos Medical (NYSE:AVNS) Stock Rating Lowered by ...

TheStreet upgraded shares of Avanos Medical from a “d+” rating to a “c” rating in a research report on Monday, January 3rd. KeyCorp lowered...

2022-04-13 - Avanos Medical, Inc. (NYSE:AVNS) Expected to Post ...

Avanos Medical, Inc. (NYSE:AVNS) Expected to Post Quarterly Sales of $195.51 Million. Posted by admin on Apr 14th, 2022.

2022-03-22 - Even after rising 4.8% this past week, Avanos Medical (NYSE:AVNS) shareholders are still down 24% over the past year

When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. Investors in Avanos Medical, Inc.

2021-08-03 - Avanos Medical, Inc. Announces Second Quarter 2021 Results

ALPHARETTA, Ga., Aug. 3, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported second quarter 2021 financial results. "Through the first-half of the year our commercial teams continue to execute well and build sales momentum across our franchises while maintaining spending dis ...

2021-05-07 - Avanos Medical, Inc. Announces First Quarter 2021 Results

ALPHARETTA, Ga., May 7, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2021 financial results. "We executed well in the first quarter highlighted by building momentum across our franchises and controlling costs, while remaining focused on the health and sa ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$410.9M20241%N/A
#2
$405.2M20247%$37.9M
#3
N/A21624%N/A
#4
$149.6M23109%$5M
#5
$5210M28917%N/A